Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
Heading into the week before Christmas, the United States Food and Drug Administration flagged Eli Lilly & Co. (NYSE:LLY) for a shortage of their new diabetes drug, Mounjaro.
Source: valuewalk.com